Giving children living with neglected diseases a fairer chance at life
Maryam Mahdi | | Interview
This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques. Read more about The Small Molecule Manufacturer here https://themedicinemaker.com/manufacture/small-but-never-forgotten
Chagas disease – described by the WHO as “silent and silenced” – is a public health concern for developing countries in Latin America where it is endemic. It is caused by the protozoan parasite, Trypanosoma cruzi, which is carried and spread by insects. Although the symptoms of the disease vary, it is responsible for approximately 14,000 deaths each year (1) and, given that the majority of people affected by the disease are children, appropriate treatments are needed. The Medicine Maker spoke to Bayer’s Maria Luisa Rodriguez, Global Program Head for the development of nifurtimox, about the challenges posed by treating children affected by Chagas disease – and how the industry could more effectively address the needs of pediatric patients with neglected diseases.
Why is pediatric drug development so important?
At the core of the pharmaceutical industry’s motivations is giving people a fair chance at life. This should begin by ensuring that children are able to lead healthy lives with necessary treatments available to help see them through periods of illness. As a parent and a person who works in the pharmaceutical industry, it is important for me and those who I work with to find solutions to the medical problems faced by children, regardless of whether they have chronic illnesses or acute conditions.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.